EG236451 Inhibitors
Phf11b, predicted to be located in the nuclear membrane and nucleoplasm and active in the nucleus, plays a crucial role in cellular processes. It is orthologous to human PHF11 and is involved in various cellular functions. Inhibition strategies encompass both direct and indirect approaches. Direct inhibitors like Vorinostat and Curcumin target specific molecular components associated with Phf11b, influencing chromatin structure and inflammatory pathways. Indirect inhibitors, such as Rapamycin and SB203580, modulate signaling cascades related to Phf11b, showcasing the complexity of its regulatory network.
Inhibition of Phf11b involves interference at multiple levels, including epigenetic modifications, chromatin remodeling, and modulation of key signaling pathways. Histone deacetylase inhibitors, like Vorinostat and Trichostatin A, alter the accessibility of the Phf11b gene through epigenetic modifications, potentially suppressing its expression. Meanwhile, inhibitors targeting pathways like NF-κB (e.g., Curcumin, BAY 11-7082) indirectly influence Phf11b expression by downregulating NF-κB-dependent transcription. Furthermore, compounds such as Wortmannin and PD98059 indirectly affect Phf11b through their impact on the PI3K-Akt and MAPK pathways, respectively. DNA-damaging agents like Cisplatin induce stress responses, potentially inhibiting Phf11b as a downstream consequence. This multifaceted approach to inhibition reflects the intricate regulatory mechanisms governing Phf11b and provides a basis for further exploration of its functional relevance in cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor, influencing the acetylation status of chromatin. Alters the accessibility of the Phf11b gene by modulating the epigenetic landscape, potentially inhibiting its expression and function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
NF-κB pathway inhibitor, suppressing inflammatory signaling. Indirectly influences Phf11b expression through the downregulation of NF-κB-dependent transcription, potentially leading to inhibition of Phf11b activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor affecting the PI3K-Akt pathway. Modulates downstream signaling cascades, potentially interfering with pathways connected to Phf11b, resulting in indirect inhibition of Phf11b. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Bromodomain inhibitor disrupting chromatin structure. Alters the accessibility of Phf11b gene by interfering with the binding of bromodomain-containing proteins, potentially leading to inhibition of Phf11b expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor influencing mTORC1 signaling. Indirectly modulates pathways related to Phf11b through mTORC1, potentially affecting Phf11b expression and activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor affecting MAPK signaling. Alters downstream signaling pathways connected to Phf11b, potentially leading to indirect inhibition of Phf11b activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor targeting the MAPK pathway. Modulates pathways related to Phf11b through MEK inhibition, potentially influencing Phf11b expression and activity indirectly. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor, impacting chromatin structure. Alters the epigenetic landscape associated with the Phf11b gene, potentially inhibiting its expression and activity through modulation of histone acetylation. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-κB pathway inhibitor. Suppresses inflammatory signaling, indirectly influencing Phf11b expression through the downregulation of NF-κB-dependent transcription, potentially leading to inhibition of Phf11b. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor affecting the JNK signaling pathway. Modulates downstream signaling pathways connected to Phf11b, potentially leading to indirect inhibition of Phf11b activity. | ||||||